Study Identifies Biomarker That Could Predict Chemotherapy Benefits for Colon Cancer Patients
July 26, 2024
July 26, 2024
MIAMI, Florida, July 26 (TNSres) -- The University of Miami's Miller School of Medicine issued the following news:
By Tara Roberts
Many people with stage 2 or stage 3 colon cancer receive additional, or adjuvant, chemotherapy following surgery. However, clinical trials have shown that this treatment doesn't improve the chances of survival for every patient.
Steven Chen, Ph.D., a researcher at Sylvester Comprehensive Cancer Center, part of the Univ . . .
By Tara Roberts
Many people with stage 2 or stage 3 colon cancer receive additional, or adjuvant, chemotherapy following surgery. However, clinical trials have shown that this treatment doesn't improve the chances of survival for every patient.
Steven Chen, Ph.D., a researcher at Sylvester Comprehensive Cancer Center, part of the Univ . . .